• Home
  • Videos
  • Subscription
  • Premier’s Global Offices
Tea Chat
Information On Tea
  • Categories

    • Featured Estates (11)
    • Health Muse (69)
    • Indian Tea (74)
    • Japan Muse (6)
    • News from Premier's Tea Limited (1)
    • Recipes (51)
    • Tea (219)
    • Tea News (8)
    • Tea Taster (15)
    • Teamoods (196)
  • Archives

    • September 2010
    • August 2010
    • July 2010
    • June 2010
    • May 2010
    • February 2010
    • January 2010
    • December 2009
    • September 2008
    • August 2008
    • July 2008
    • June 2008
    • May 2008
    • April 2008
    • March 2008
    • February 2008
    • January 2008
    • December 2007
    • November 2007
    • October 2007
    • September 2007
    • August 2007
    • July 2007
    • June 2007
    • May 2007
    • April 2007
    • February 2007
  • Links

    • Log in
    • Premier’s Japan
    • Premier’s India
    • Premier's Estonia
    • Premier’s Russia
    • Premier's Tea Ltd (Global)
  • Online Nursing Programs


Jun 08

Believe it or NOT!!!

Health Muse, Tea News Add comments

Came across an article recently, and we at Premier’s do not necessarily propagate Tea & Health and that’s why I leave it for our readers to decide. But it is interesting that this wonderful leaf could and if it has, then we all should admire the curative properties.

“Green Tea Compound Slowed Chronic Lymphocytic  Leukemia”

“A key component of green tea has shown promise as a non-toxic treatment for chronic lymphocytic leukemia (CLL).

Researchers at the Mayo Clinic are now in the second phase of trials with early-stage, asymptomatic patients to explore the potential of epigallocatechin gallate (EGCG) to strike a blow against this type of leukemia.

Click here to find  out more!

“The benefits we have seen in most CLL patients who use the chemical suggest that it has modest clinical activity and may be useful for stabilizing this form of leukemia, potentially slowing it down,” lead author Dr. Tait Shanafelt, a Mayo Clinic hematologist, said in a news release.

Shanafelt’s team is slated to present its findings Monday at the American Society of Clinical Oncology annual meeting, in Chicago.

The latest research builds on earlier Mayo lab work from eight years ago, during which EGCG’s potential to curtail the survival of CLL leukemia cells was first noted. The current trial marks the first time this green tea extract has been studied in actual patients as a treatment option for an illness that is described as a hybrid between leukemia and lymphoma.”….

If you have read till the above line and feel excited to know more

Please visit  U.S. News.com

Send us your thoughts!!!


Tags: Health Muse, Tea News

Comments are closed.

Powered by Web Design India

cssandhtml